Consumer
preference
studies
are
providing
information
about
the
safety
of
raw
and
processed
oysters
|
|
Post-harvest
treatments
have
been
developed
to
eliminate
the
potential
of
Vibrios,
particularly
V.
vulnificus,
in
raw
and
processed
oysters.
Forecasting
of
disease-related
mortality
and
improved
coastal
wastewater
treatment
of
oyster
processing
houses
has
advanced
significantly.
Consumer
preference
studies
are
providing
information
about
the
safety
of
raw
and
processed
oysters
while
developing
a
stronger
foundation
of
understanding
that
is
helping
the
oyster
industry
assess
public
attitudes
toward
value-added
processing. |
|
 |
Sea
Grant
develops
quantitative
shellfish
management
models
|
|
Quantitative
shellfish
management
models have
been developed
and are in
use by resource
managers
in the Chesapeake
and Delaware
bays to adjust
harvest seasons,
quotas and
other management
options where
disease is
a key factor.
Simulation
models are
helping managers
investigate
effects of
long-term
climate variation
on MSX disease
prevalence
and intensity
in oyster
populations
for the Delaware
and Chesapeake
bays.
|
|
|
Sea Grant identifies inhibitors
|
|
DNA
libraries,
genetic
markers
and
pedigreed
families
determined
for
C.
verginica
through
genetic
engineering
and
biotechnology
are
contributing
to
the
production
of
disease-resistant
oysters.
Protease
inhibitory
(PI)
activity
is
used
as
an
index
of
disease
resistance—by
identifying
protease
inhibitors
and
lytic
peptides
in
oysters
that
are
naturally
resistant
to
Perkinsus
marinus
(dermo),
two
applications
are
now
on
the
horizon. |
|
